Viewing Study NCT03412266


Ignite Creation Date: 2025-12-24 @ 4:15 PM
Ignite Modification Date: 2026-01-25 @ 7:42 AM
Study NCT ID: NCT03412266
Status: UNKNOWN
Last Update Posted: 2022-04-20
First Post: 2018-01-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RIC Regimen for Low- and Intermediate-risk MDS Receiving Haplo-HSCT
Sponsor: Peking University People's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Myelodysplastic Syndromes View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RIC regimen; MDS; haplo-HSCT; survival View